Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly improve outcomes for patients with colorectal peritoneal metastases. Median overall survival with complete cytoreductive clearance is 43 months, compared to 10-18 months with systemic chemotherapy alone. Patients with the KRAS G12V mutation have a median overall survival of 34 months, significantly lower than the wild-type […]
Category: Intestine and Lower Gastrointestinal Tract
New AI Tool Predicts Anastomotic Leakage After Surgery
A machine learning model can predict anastomotic leakage within 24 hours post-minimally invasive colorectal surgery, enhancing patient selection and safety. Incidence of anastomotic leakage in the study was 9.8%. The model achieved an AUC of 0.819 and a negative predictive value of 97.9%. This reliable early warning system allows for safer discharges, even with a […]
Fluorescence Imaging Cuts Anastomotic Leakage in Colorectal Surgery
Indocyanine green fluorescence angiography significantly lowers anastomotic leakage rates in colorectal surgery, improving patient outcomes. Anastomotic leakage was 7.9% in the indocyanine green group compared to 11.6% in controls (risk ratio 0.69, p < .001). The finding is robust, supported by a review of 4,636 patients across seven trials. Surgeons should consider using fluorescence angiography […]
Five-Year Outcomes: Laser vs. Traditional Hemorrhoid Surgery
A new study compares long-term results of laser hemorrhoidoplasty, excisional hemorrhoidectomy, and sutured mucopexy for treating second- and third-degree hemorrhoids. 5-year symptom recurrence rates: 24% (excisional), 29% (laser), 44% (sutured), with no statistical significance. Recurrence details: bleeding (18% excisional, 31% laser, 31% sutured) and prolapse (12% excisional, 23% laser, 34% sutured). Excisional hemorrhoidectomy yields the […]
New Robotic Platform for Colorectal Surgery Expands Access
A newly approved Japanese robotic surgical platform shows promise for colorectal surgeries by improving outcomes and cost-effectiveness. Comparable to U.S. systems, it offers shorter learning curves and improved ergonomics. Early results from two surgeries show no complications and effective oncological outcomes. This platform could make robotic surgery more accessible to surgeons and patients worldwide. Ongoing […]
Obesity Impacts Short-Term Outcomes After Laparoscopic Colectomy
Obese patients face higher readmission rates after laparoscopic colectomy, influencing surgical decisions. Obese patients had longer surgeries (median 175 vs. 164 min, p=0.004) and higher 30-day readmission (11.8% vs. 8.8%, p=0.04). No significant differences in major complications, reoperation, or mortality between obese and non-obese patients. Consider the increased readmission risk when selecting candidates for surgery, […]
Integrated Response Metrics Enhance Prognosis in CRLM Surgery
Combining anatomical and histologic responses to neoadjuvant therapy improves predicting recurrence in colorectal liver metastases (CRLM) after hepatectomy. Median recurrence-free survival (RFS) was 15.87 months for 483 patients. Early recurrence occurred in 36.9%, linked to poor histologic and anatomical responses. Understanding these combined metrics helps tailor patient selection and surgical planning for better outcomes. Intrahepatic […]
Impact of Surgical Margins in Colorectal Liver Metastases
Surgical margins during liver resection for colorectal metastases are crucial, especially given tumor genetics. R1p margins significantly worsen survival (53% vs. 61% for R0; p < 0.0001), particularly in KRAS-mutated tumors. R1p margins also correlate with increased recurrence rates, whereas R1v margins showed no significant risk across molecular groups. Surgeons should prioritize achieving R0 resection, […]
AI System Accurately Triages Ostomy Photos from Patients
An AI pipeline effectively categorizes patient-submitted ostomy photos, improving triage efficiency. 43.9% of 538 images were deemed to have obstructed views, while 5.6% were healthy. The best model, Clip-ViT, achieved an impressive area under the curve of 0.99 and precision of 0.87. This technology has potential to streamline post-operative care by prioritizing cases requiring in-person […]
Bevacizumab strategies enhance surgical options in liver metastases
Patients with initially unresectable colorectal liver metastases benefit from certain induction therapies that increase surgical conversion potential. Bevacizumab plus triplet chemotherapy showed a 99% probability of improving R0-1 resection rates and progression-free survival. Bevacizumab plus doublet chemotherapy offers a more balanced benefit-risk profile, favoring safer patient outcomes. Consider adjusting induction regimens based on genetic tumor […]